These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6384442)

  • 1. A rapid separation of A14-125I-insulin from heterogeneous iodination mixtures by high performance liquid chromatography (HPLC).
    Marchetti P; Benzi L; Cecchetti P; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(1):31-4. PubMed ID: 6384442
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical properties of A14-125I-monoiodoinsulin purified by high performance liquid chromatography.
    Benzi L; Marchetti P; Cecchetti P; Caricato F; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(2):81-4. PubMed ID: 6392492
    [No Abstract]   [Full Text] [Related]  

  • 3. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
    Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
    [No Abstract]   [Full Text] [Related]  

  • 5. A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.
    Stentz FB; Wright RK; Kitabchi AE
    Diabetes; 1982 Dec; 31(12):1128-31. PubMed ID: 6757025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
    Stentz FB; Harris HL; Kitabchi AE
    Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary use of gel permeation and reversed-phase liquid chromatography for the analysis of A14-[125I]insulin and its degradation products in isolated human monocytes.
    Marchetti P; Benzi L; Trischitta V; Brunetti A; Cecchetti P; Ciccarone AM; Pezzino V; Vigneri R; Navalesi R
    J Chromatogr; 1986 Apr; 377():339-44. PubMed ID: 3519641
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC).
    Kalant D; Crawhall JC; Posner BI
    Biochem Med; 1985 Oct; 34(2):230-40. PubMed ID: 3910033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation, isolation and characterization of the four monoiodinated insulin tracers using reversed-phase high-performance liquid chromatography.
    Welinder BS; Linde S; Hansen B
    J Chromatogr; 1983 Aug; 265(2):301-9. PubMed ID: 6355130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
    Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
    Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of biologically active mono-125I-insulin of high specific activity.
    Cresto JC; Udrisar DP; Camberos MC; Basabe JC; Gómez Acuña P; de Majo SF
    Acta Physiol Lat Am; 1981; 31(1):13-24. PubMed ID: 6765006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid, high-yield method of producing mono-[125I]A14 iodoinsulin.
    Lioubin MN; Meier MD; Ginsberg BH
    Prep Biochem; 1984; 14(4):303-11. PubMed ID: 6393119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of A14-tyrosyl [125I]iodoinsulin using C18 reverse-phase cartridges.
    De Leo DT; Helmerhorst E
    Anal Biochem; 1992 Oct; 206(1):207-10. PubMed ID: 1456436
    [No Abstract]   [Full Text] [Related]  

  • 15. The preparation of porcine (Tyr-A14-2H) insulin and its characterization by mass spectrometry.
    Savoy LA; Vuagnat P; Rose K; Halstrøm J; Jørgensen KH; Kovacs K
    Protein Eng; 1988 Oct; 2(4):313-5. PubMed ID: 3074308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity in tyrosyl iodination sites in human thyroglobulin.
    Xiao S; Dorris ML; Rawitch AB; Taurog A
    Arch Biochem Biophys; 1996 Oct; 334(2):284-94. PubMed ID: 8900403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of insulins in bovine and porcine insulin preparations by high-performance liquid chromatography].
    Ohta M; Tokunaga H; Kimura T; Satoh H; Yamaha T
    Eisei Shikenjo Hokoku; 1984; (102):33-5. PubMed ID: 6398093
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the human insulin receptor.
    Fabry M; Brandenburg D
    Biol Chem Hoppe Seyler; 1992 Sep; 373(9):915-23. PubMed ID: 1466789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthograde transport and release of insulin-like growth factor I from the inferior olive to the cerebellum.
    Nieto-Bona MP; Garcia-Segura LM; Torres-Aleman I
    J Neurosci Res; 1993 Dec; 36(5):520-7. PubMed ID: 7511697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
    Linde S; Hansen B
    Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.